{"organizations": [], "uuid": "d1d4a96887f7968edd47a1a270536e03b6ab859b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-avexis-says-merger-deal-with-novar/brief-avexis-says-merger-deal-with-novartis-includes-that-under-certain-circumstances-co-will-pay-284-mln-termination-fee-idUSFWN1RM0RK", "country": "US", "domain_rank": 408, "title": "BRIEF-AveXis Says Merger Deal With Novartis Includes That Under Certain Circumstances, Co Will Pay $284 Mln Termination Fee", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T00:42:00.000+03:00", "replies_count": 0, "uuid": "d1d4a96887f7968edd47a1a270536e03b6ab859b"}, "author": "", "url": "https://www.reuters.com/article/brief-avexis-says-merger-deal-with-novar/brief-avexis-says-merger-deal-with-novartis-includes-that-under-certain-circumstances-co-will-pay-284-mln-termination-fee-idUSFWN1RM0RK", "ord_in_thread": 0, "title": "BRIEF-AveXis Says Merger Deal With Novartis Includes That Under Certain Circumstances, Co Will Pay $284 Mln Termination Fee", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "novartis", "sentiment": "none"}, {"name": "avexis inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9 (Reuters) - AveXis Inc:\n* AVEXIS - MERGER DEAL WITH NOVARTIS INCLUDES THAT UNDER CERTAIN SPECIFIED CIRCUMSTANCES, CO WILL BE REQUIRED TO PAY $284 MLN TERMINATION FEE TO NOVARTIS\n* AVEXIS INC - IN CASE OF TERMINATION OF DEAL, NOVARTIS WILL BE REQUIRED TO PAY TO CO A \"REVERSE TERMINATION FEE\" EQUAL TO $437 MLN - SEC FILING Source text: ( bit.ly/2qiFq1U ) Further company coverage:\n ", "external_links": [], "published": "2018-04-10T00:42:00.000+03:00", "crawled": "2018-04-10T01:04:32.000+03:00", "highlightTitle": ""}